Corporate Profile
CVRx® is a leader in the development of safe and effective therapies to address unmet needs in cardiovascular disease. Headquartered near Minneapolis, Minn., CVRx is dedicated to improving patient outcomes, quality of life and overall cardiovascular health via our novel baroreceptor neuromodulation therapies.
(Common Stock)
1:16 AM EDT / 06.03.2023
Data Provided by Refinitiv.
Minimum 15 minutes delayed.
Latest Quarterly Earnings
Financial News
Events
Jun 8, 2023 at 10:20 AM EDT
Apr 27, 2023 at 5:00 PM EDT
Mar 21, 2023 at 4:30 PM EDT
CVRx Shares Preliminary Results of the BeAT-HF Post-Market Clinical Trial
